HCG's Profit Surge Signals Strong Turnaround in Q1
Healthcare Global's profit jumped 175% year-on-year, with revenue up 13.4%, marking a sharp recovery from a weak prior quarter.
HCG's Q1 FY27 results show a powerful profit rebound, surging 175% YoY on steady revenue growth. The net profit margin expanded significantly, indicating improved operational performance.
Healthcare Global Enterprises (HCG) delivered a powerful earnings rebound in the first quarter of FY27, with profit soaring on both a yearly and quarterly basis. This marks a significant turnaround from the volatile profitability seen over the past year, driven by solid revenue growth and a sharp expansion in net profit margin.
The company reported a profit of ₹16.46 crore for Q1 FY27, a staggering 175.3% increase from the ₹5.98 crore earned in the same quarter last year. Sequentially, profit surged over 300% from the ₹4.04 crore recorded in Q4 FY26. Revenue grew healthily by 13.4% year-on-year to ₹695.1 crore, and also improved 6.6% from the previous quarter. This combination of rising sales and surging profit pushed the net profit margin up to 2.4%, a substantial 140 basis point improvement from the 1.0% margin in Q1 FY26.
A look at the last five quarters shows the extent of this recovery, moving from a loss in Q3 FY26 back to robust profitability.
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin (%)
| Metric | CurrentQ1 FY27 | PreviousQ4 FY26 | Same quarter LYQ1 FY26 |
|---|---|---|---|
| Revenue (₹ Cr) | 695.1YoY +13% | 652.33 | 613.16 |
| Profit (₹ Cr) | 16.46YoY +175% | 4.04 | 5.98 |
| Net Profit Margin (%) | 2.4YoY +140% | 0.6 | 1.0 |
Key Points
- The trailing twelve-month (TTM) profit stands at ₹33.26 crore on revenue of ₹2,627.35 crore, yielding a TTM net profit margin of 1.3%.
- The stock has delivered strong long-term returns, with a 97.9% gain over the past three years, translating to a 25.6% annualised return (CAGR).
- The current valuation reflects high growth expectations, with the stock trading at a P/E of 168.9, a significant premium to the industry average of 67.5.
The latest quarter demonstrates HCG's ability to translate consistent revenue growth into significantly stronger bottom-line performance, setting a positive tone for the new fiscal year.
Live Chart
· HCG
(BSE)
ISIN: INE075I01017
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.